T5	Subject 22 47	18 other paediatric cases
T6	Effect 51 79	naphthylimidazoline exposure
T7	Treatment 51 70	naphthylimidazoline
T9	Population 22 24	18
T10	Age 31 41	paediatric
T11	Drug 51 70	naphthylimidazoline
T8	Adverse_event 4 18	symptomatology
E1	Adverse_event:T8 
